Compound Understanding and Pre-Development Planning
Physicochemical Characterisation Before any bioanalytical method development commences, the analyst must gather comprehensive physicochemical data...
Physicochemical Characterisation
Before any bioanalytical method development commences, the analyst must gather comprehensive physicochemical data concerning the drug substance, since these properties dictate the ionisation mode, sample preparation strategy, and anticipated extraction recovery. Molecular weight and formula determine the mass-to-charge ratio to be monitored during mass spectrometric analysis, while ionisation constant governs the selection of positive or negative electrospray ionisation mode, with basic compounds of higher pKa typically favouring positive ionisation and acidic compounds favouring negative ionisation. The octanol-water partition coefficient informs the choice between liquid-liquid extraction, which is preferred for lipophilic analytes, and protein precipitation or solid phase extraction, which are more suitable for hydrophilic compounds. Plasma protein binding, metabolic pathway information, blood-to-plasma partition ratio, and chemical stability data collectively inform decisions regarding matrix selection, back-conversion risk assessment, and the design of appropriate stability experiments.
Internal Standard Selection
Selection of an appropriate internal standard is a critical determinant of bioanalytical method accuracy, since the internal standard compensates for variability introduced during sample extraction, ionisation, and instrumental analysis. Stable isotope-labelled internal standards, in which one or more atoms of the analyte molecule are replaced with a stable isotope such as deuterium or carbon-thirteen, represent the gold standard because they exhibit near-identical chromatographic and ionisation behaviour to the native analyte while remaining mass-spectrometrically distinguishable. Structural analogues and stable isotopes of known metabolites represent alternative options where isotopically labelled material is unavailable. An internal standard must never be a metabolite of the analyte of interest, owing to the risk of in vitro back-conversion during sample processing, and its absence from blank biological matrix must always be confirmed prior to method development.